Versant Ventures Iv, Llc - Net Worth and Insider Trading
Versant Ventures Iv, Llc Net Worth
The estimated net worth of Versant Ventures Iv, Llc is at least $108 Million dollars as of 2024-11-13. Versant Ventures Iv, Llc is the 10% Owner of Audentes Therapeutics Inc and owns about 1,806,832 shares of Audentes Therapeutics Inc (BOLD) stock worth over $108 Million. Details can be seen in Versant Ventures Iv, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Versant Ventures Iv, Llc has not made any transactions after 2016-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Versant Ventures Iv, Llc
Versant Ventures Iv, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Versant Ventures Iv, Llc owns 8 companies in total, including IVERIC bio Inc (ISEE) , Inari Medical Inc (NARI) , and Oyster Point Pharma Inc (OYST) among others .
Click here to see the complete history of Versant Ventures Iv, Llc’s form 4 insider trades.
Insider Ownership Summary of Versant Ventures Iv, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ISEE | IVERIC bio Inc | 2018-10-30 | 10 percent owner |
| NARI | Inari Medical Inc | 2020-11-17 | 10 percent owner |
| OYST | Oyster Point Pharma Inc | 2019-10-30 | 10 percent owner |
 | | 2018-04-20 | 10 percent owner |
| | 2016-07-25 | 10 percent owner |
| | 2016-05-11 | 10 percent owner |
| | 2011-11-15 | 10 percent owner |
| | 2022-04-29 | 10 percent owner |
Versant Ventures Iv, Llc Latest Holdings Summary
Versant Ventures Iv, Llc currently owns a total of 1 stock. Versant Ventures Iv, Llc owns 1,806,832 shares of Audentes Therapeutics Inc (BOLD) as of July 25, 2016, with a value of $108 Million.
Latest Holdings of Versant Ventures Iv, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BOLD | Audentes Therapeutics Inc | 2016-07-25 | 1,806,832 | 59.97 | 108,355,715 |
Holding Weightings of Versant Ventures Iv, Llc
Versant Ventures Iv, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Versant Ventures Iv, Llc has made a total of 0 transactions in Audentes Therapeutics Inc (BOLD) over the past 5 years. The most-recent trade in Audentes Therapeutics Inc is the acquisition of 35,000 shares on July 25, 2016, which cost Versant Ventures Iv, Llc around $525,000.
Insider Trading History of Versant Ventures Iv, Llc
- 1
Versant Ventures Iv, Llc Trading Performance
GuruFocus tracks the stock performance after each of Versant Ventures Iv, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Ventures Iv, Llc is 15.79%. GuruFocus also compares Versant Ventures Iv, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Ventures Iv, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Versant Ventures Iv, Llc's insider trading performs compared to the benchmark.
Performance of Versant Ventures Iv, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.42 | | | | | |
| Relative Return to S&P 500(%) | 2.24 | | | | | |
Versant Ventures Iv, Llc Ownership Network
Ownership Network List of Versant Ventures Iv, Llc
Ownership Network Relation of Versant Ventures Iv, Llc
Versant Ventures Iv, Llc Owned Company Details
What does IVERIC bio Inc do?
Who are the key executives at IVERIC bio Inc?
Versant Ventures Iv, Llc is the 10 percent owner of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .
IVERIC bio Inc (ISEE) Insider Trades Summary
Over the past 18 months, Versant Ventures Iv, Llc made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 40,000 shares made by Keith Westby ,
In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,000 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,000 shares.
IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.
IVERIC bio Inc Insider Transactions
Versant Ventures Iv, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Versant Ventures Iv, Llc. You might contact Versant Ventures Iv, Llc via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
